ArticleKidney international reports2017
Lysozyme-Induced Nephropathy.
Article in Kidney international reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 37 citations in OpenAlex.
- A case of lysozyme-induced nephropathy with improved renal function following treatment for chronic myelomonocytic leukemia.CEN case reports · 2026Article
- Two cases of lysozyme-induced nephropathy with varying underlying diseases: myelodysplastic syndrome and chronic myelomonocytic leukemia.CEN case reports · 2026Article
- Lysozyme-Associated Nephropathy in Myeloid Neoplasms: A Clinicopathological and Mass Spectrometric Study of Two Cases.Nephron · 2026Article
- When leukemia harms the kidneys: a scoping review of lysozyme-induced nephropathy in chronic myeloid leukemia and chronic myelomonocytic leukemia.Annals of medicine and surgery (2012) · 2025Review
- A case of chronic myelomonocytic related lysozyme-induced nephropathy.BMC nephrology · 2025Article
- Kidney and Urinary Tract Involvement in Chronic Myelomonocytic Leukemia.Kidney medicine · 2024Review
- Chronic Myelomonocytic Leukemia Patients With Lysozyme Nephropathy and Renal Infiltration Display Markers of Severe Disease.Kidney international reports · 2023Article
- Lysozyme-induced nephropathy due to systemic granulomatous disease.Clinical case reports · 2023Article
- Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia.Current treatment options in oncology · 2023Review
- Clinicopathologic Spectrum of Lysozyme-Associated Nephropathy.Kidney international reports · 2023Article
- Rare Case of Refractory Hypokalemia in a Patient with Acute Monocytic Leukemia.The American journal of case reports · 2023Review
- Article
- Article
- How I diagnose and treat chronic myelomonocytic leukemia.Haematologica · 2022Article
- A rare cause of acute kidney injury with chronic myelomonocytic leukemia.CEN case reports · 2021Article
- Kidney Involvement in Patients With Chronic Myelomonocytic Leukemia or BCR-ABL-Negative Myeloproliferative Neoplasms.Kidney international reports · 2021Article
- Molecularly Imprinted Polyscopoletin for the Electrochemical Detection of the Chronic Disease Marker Lysozyme.Biosensors · 2020Article
- AKI and Hypercalcemia in a Patient with Weakness and Fatigue.Kidney360 · 2020Article
- Pathological value of lysozyme staining for renal sarcoidosis.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.